Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.Pediatric Blood & Cancer|March 2, 2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906W Paul Bowman, Eric L Larsen, Meenakshi Devidas, et al.Blood|September 24, 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studiesKatelyn Purvis, Yinmei Zhou, Seth E Karol, et al.The Lancet. Oncology|March 25, 2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective studyChing-Hon Pui, Deqing Pei, Elaine Coustan-Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoidsSue C Kaste, Deqing Pei, Cheng Cheng, et al.JCO Oncology Practice|September 8, 2025
Chronic Health Conditions and Academic Achievement: A Childhood Cancer Survivor Study ReportLisa Bashore, Rachel K Peterson, Chenghong Li, et al.The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyKirk R Schultz, W Paul Bowman, Alexander Aledo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.Pageof 6